These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1031 related articles for article (PubMed ID: 2537334)
1. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334 [TBL] [Abstract][Full Text] [Related]
2. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men. Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578 [TBL] [Abstract][Full Text] [Related]
3. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN; Wakefield GB; Island DP; Hoffman PG; LePage ME; Chan RL; Nerenberg CA; Kovacs WJ J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388 [TBL] [Abstract][Full Text] [Related]
4. Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men. Lindner J; Rivier JE; Vale WW; Pavlou SN J Clin Endocrinol Metab; 1990 Apr; 70(4):1219-24. PubMed ID: 1690747 [TBL] [Abstract][Full Text] [Related]
5. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH. Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622 [TBL] [Abstract][Full Text] [Related]
6. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948 [TBL] [Abstract][Full Text] [Related]
7. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration. Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men. Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592 [TBL] [Abstract][Full Text] [Related]
9. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum. McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381 [TBL] [Abstract][Full Text] [Related]
10. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men. Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329 [TBL] [Abstract][Full Text] [Related]
12. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix). Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man. Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS J Androl; 1994; 15(1):22-8. PubMed ID: 8188535 [TBL] [Abstract][Full Text] [Related]
14. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men. Salameh W; Bhasin S; Steiner B; McAdams LA; Peterson M; Swerdloff R Fertil Steril; 1991 Jan; 55(1):156-64. PubMed ID: 1898888 [TBL] [Abstract][Full Text] [Related]
15. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido. Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518 [TBL] [Abstract][Full Text] [Related]
16. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men. Tenover JS; Dahl KD; Vale WW; Rivier JE; Bremner WJ J Clin Endocrinol Metab; 1990 Oct; 71(4):881-8. PubMed ID: 2205625 [TBL] [Abstract][Full Text] [Related]
17. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men. Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043 [TBL] [Abstract][Full Text] [Related]
18. Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75). Bokser L; Srkalovic G; Szepeshazi K; Schally AV Neuroendocrinology; 1991 Aug; 54(2):136-45. PubMed ID: 1662786 [TBL] [Abstract][Full Text] [Related]
19. Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men. Pavlou SN; Interlandi JW; Wakefield G; Island DP; Rivier J; Vale W; Kovacs WJ J Clin Endocrinol Metab; 1987 May; 64(5):1070-4. PubMed ID: 3104387 [TBL] [Abstract][Full Text] [Related]
20. Recovery of pituitary-gonadal function in male rats after long-term suppression induced by a single injection of microcapsules of LH-RH antagonist cetrorelix (SB-75). Pinski J; Yano T; Szepeshazi K; Groot K; Schally AV J Androl; 1993; 14(3):164-9. PubMed ID: 8407570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]